Product news

Share this article:
Novo Nordisk AS and Sciele Pharma Inc. announced on Wednesday the launch of a type 2 diabetes combination drug. PrandiMet combines Novo Nordisk's Prandin (repaglinide) with the generic drug metformin.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M inVISION